Study of sudapyridine in healthy Chinese men
Part of Infections clinical trials.
This trial tests how Sudapyridine (WX-081) moves through the body in healthy Chinese men. It helps researchers understand the drug's effects and safety before moving to later studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy man between 18 and 45 years old.
- Your body mass index (BMI) must be between 19 and 26, and you must weigh at least 110 pounds (50 kg).
- You have no major medical conditions, such as heart disease, liver problems, or infections like hepatitis or HIV.
- You have not taken any prescription or over-the-counter medications, herbs, or supplements in the past 2 weeks.
- You have no history of stomach or intestinal surgery that could affect drug absorption.
- You are willing to follow the study schedule and give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for healthy men to see how the body processes an experimental drug. It will help researchers understand how the drug is absorbed, broken down, and removed from the body.
This study tracks how a new drug, called FXS4640, moves through the body in healthy men. It uses a small amount of radioactivity to follow the drug, which helps researchers understand how it is absorbed and cleared. Participation involves staying at the clinic for several days for tests and samples.
This trial tests a new medicine called SPH9788 in healthy people to see how the body handles it. Volunteers must be generally healthy and follow lifestyle rules to help researchers understand the drug's safety and effects.
This trial tests a new medication called SV003 in healthy people to see if it's safe and how the body processes it. You may be able to join if you are in good health and meet certain weight and lifestyle requirements.
This trial tests a new drug called IPG1094 in healthy people to see if it's safe and how the body handles it. Healthy volunteers may join to help find the right dose for future studies.
This trial tests how a new drug, sudapyridine, interacts with two common medicines (itraconazole and rifampin) and whether food changes how the drug is absorbed. It is for healthy adults to help find the right dosing and safety for future patients.
Hear when a new TB trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.